Navigation Links
Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
Date:7/17/2008

- Once-daily TMC278, the third anti-HIV compound to be developed in Tibotec

virology portfolio -

YARDLEY, Pa., July 17 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. announced today that two major phase III efficacy trials examining TMC278, its investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in treatment-naive adults with HIV-1, are now recruiting patients. The global trials will compare the efficacy, safety and tolerability of TMC278 (25 mg) once daily oral tablet versus efavirenz (EFV), each coadministered with a background regimen of two nucleoside/nucleotide reverse transcriptase inhibitors (N[t]RTIs), in treatment-naive HIV-1-infected adults.

"Preliminary data have shown TMC278 to be active against HIV for patients who have not previously received treatment," Roger Pomerantz, MD, President of Tibotec Research and Development. "These phase III studies will provide important information on the safety and efficacy of this potential new treatment."

The first phase III, double-blind, randomized study, known as TMC278-C209 or ECHO (Efficacy Comparison in treatment-naive HIV-infected subjects Of TMC278 and EFV), will evaluate TMC278 (25 mg) once daily oral tablet versus EFV (600 mg) once daily, when combined with a fixed background regimen consisting of emtricitabine + tenofovir disoproxil fumarate. A second phase III, double-blind randomized study, known as TMC278-C215 or THRIVE (TMC278 against HIV, in a once daily RegImen Versus Efavirenz), will evaluate TMC278 (25 mg) once daily versus EFV (600 mg) once daily, when combined with an investigator-selected background regimen consisting of two N[t]RTIs (abacavir + lamivudine or tenofovir disoproxil fumarate + emtricitabine or zidovudine + lamivudine).

Each study will be conducted at more than 100 sites in over 20 countries, including the U.S., Canada and several countries in Latin America, among others, and will seek to enroll approximat
'/>"/>

SOURCE Tibotec Pharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
2. Maine Natural Health Company Conducts Dental Clinical Trial
3. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
4. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
5. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
6. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
7. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
8. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
9. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
10. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
11. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... WILMINGTON, Del. , March 30, 2015  Rigrodsky & ... Auspex Pharmaceuticals, Inc. (NASDAQ GM: ASPX )? , ... 30, 2015? , Do you think the proposed buyout ... discuss your rights? Rigrodsky & Long, ... against the board of directors of Auspex Pharmaceuticals, Inc. ("Auspex" ...
(Date:3/30/2015)... DIEGO , March 30, 2015  Orexigen ... that Tom Cannell has joined as ... global commercialization of Contrave® /Mysimba™ (naltrexone HCl / ... aspects of Orexigen,s global commercial strategy, assuming responsibilities ... successfully leading Orexigen,s commercial effort through the U.S. ...
(Date:3/30/2015)... 30, 2015  New York College of Health Professions ... Properties portfolio with U.S. Patent #8,996,098 donated by its ... represents a surgical instrument that allows surgeons to view ... were in the traditional format of a slide that ... databases during surgery, thus providing the surgeon real time ...
Breaking Medicine Technology:AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3
... (Nasdaq: YDNT ) today announced that it will ... on-demand web cast conference call on Thursday, October 21, 2010 ... the call will be available through InterCall at http://tinyurl.com/Quarter32010 ... available through the Company,s website, www.ydnt.com . ...
... one of the world,s largest and most sophisticated pharmacies ... (D-Nev.), today said innovative companies such as Medco Health ... bright future for a sustainable healthcare system for America ... Nevada by providing employment opportunities for skilled healthcare professionals. ...
Cached Medicine Technology:Young Innovations, Inc. Provides 3rd Quarter Conference Call Details 2Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevada's Future 2Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevada's Future 3
(Date:3/30/2015)... Georgia (PRWEB) March 30, 2015 Innovaacom, ... healthcare professionals worldwide, today announced it is expanding its ... solutions for this area of the world comes at ... rallying around consumer demand for better healthcare. A rapidly ... healthcare system improvements and advances in medicine in Asia. ...
(Date:3/30/2015)... 2015 A key protein previously implicated ... an important role in the response to viral infection, ... Icahn School of Medicine at Mount Sinai published today ... been associated with inflammation, part of the body’s response ... home in to attack invaders like bacteria and viruses, ...
(Date:3/30/2015)... According to a recently published report ... market will continue to dominate the European soft tissue ... to increasing numbers of ventral hernias, and the adoption ... significantly large market share represented by ventral hernia repair ... seeing a growing use of expensive biologics,” explains Dr. ...
(Date:3/30/2015)... In a recent report published by ... is championing effective drug and alcohol treatment for victims ... recover funds to stabilize the addiction treatment programs, and ... drug and alcohol addiction. Harbor Village Detox is extending ... use disorders in New Jersey, in hopes to help ...
(Date:3/30/2015)... March 30, 2015 Vancouver personal injury ... the majority of cases taken up by the firm ... that the lawyers help protect the interests of their ... court process. The announcement comes across as an achievement ... is to provide convenience to their client, without compromising ...
Breaking Medicine News(10 mins):Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2
... beware. You may be more prone to an alcohol-induced ... from the Jefferson Headache Center. The research will be ... Society for Neuroscience, in Chicago. Until now, studying ... headaches has not been possible in an animal model, ...
... like norepinephrine, serotonin, and dopamine, are regulated a ... Current drugs for depression target the regulatory process for ... appear to work in other cases. Recent ... in the brain, are key players in the management ...
... the pain, experts say , SUNDAY, Oct. 18 (HealthDay News) -- ... it,s no surprise that children will try to flee, scream, cry ... year. , "The good news is that there are several ... when getting a needlestick -- whether it,s a flu shot, a ...
... CHICAGO Epileptic seizures are the most dramatic and ... when a person abruptly stops a long-term or chronic ... calcium ions into brain cells via voltage-gated calcium channels ... withdrawal seizures, because blocking this flow suppresses these seizures. ...
... disorder more likely to die within a year of ... News) -- Veterans with post-traumatic stress disorder face an ... surgery is performed years after they have completed their ... data on 1,792 male veterans who had major non-cardiac, ...
... BOCA RATON, Fla., Oct. 16 Certain cookie diets recently ... nutrition and having no apparent health benefits. Smart for Life ... it is a healthy lifestyle featuring products that are all-natural, ... Smart for Life is a healthy lifestyle that has become ...
Cached Medicine News:Health News:Migraine sufferers more prone to hangover headache 2Health News:Post-Traumatic Stress May Raise Death Risks 2Health News:Smart for Life(TM) Cookie Diet Provides Nutrients 2Health News:Smart for Life(TM) Cookie Diet Provides Nutrients 3
... 2201 is ideal for applications such ... of heat. , ,The autoclavable handpiece ... of reusable thermal cautery electrodes, allowing ... to perform a wide variety of ...
Non-Cantilevered, "Teardrop" Ringed Forceps. ("fixation clamp") For vasectomy and other procedures. Ring ovoid approximately 6.0 mm in diameter....
... Stethoscope Module is an inconspicuous, lightweight, battery-operated instrument ... hear body functions amplified., ,The module controls ... switch, a tone switch, a stethoscope hearing aid ... switch will allow the user to select between ...
... ring receiver type earmold for ... of your ears are required. ... for the ear are distributed ... hearing healthcare providers. These providers ...
Medicine Products: